Literature DB >> 16382347

Neurophysiological investigation of hepatic encephalopathy.

Piero Amodio1, Angelo Gatta.   

Abstract

The neurophysiological tools used to study hepatic encephalopathy (HE) are the electroencephalogram (EEG) and the evoked potentials (EPs), both exogenous and endogenous. These tools are used (1) to diagnose HE in patients with severe liver disease and mental alteration, (2) to grade overt HE and monitor the effect of treatment for HE, (3) to diagnose minimal HE (4) to predict the occurrence of episodes of overt HE or liver-related death. The rationale for the use of each of these tools together with their theoretical and practical role is reviewed.

Entities:  

Mesh:

Year:  2005        PMID: 16382347     DOI: 10.1007/s11011-005-7921-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  67 in total

1.  A novel spatio-temporal decomposition of the EEG: derivation, validation and clinical application.

Authors:  Clive Jackson; Michael Sherratt
Journal:  Clin Neurophysiol       Date:  2004-01       Impact factor: 3.708

2.  Visual and auditory evoked responses in acute severe hepatitis.

Authors:  I M Sawhney; P K Verma; R K Dhiman; J S Chopra; A Sharma; Y K Chawla; J B Dilawari
Journal:  J Gastroenterol Hepatol       Date:  1997-07       Impact factor: 4.029

3.  Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy.

Authors:  C L Yen; Y F Liaw
Journal:  Hepatogastroenterology       Date:  1990-06

4.  Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts.

Authors:  Ludwig Kramer; Edith Bauer; Alexandra Gendo; Georg Funk; Christian Madl; Johann Pidlich; Alfred Gangl
Journal:  Am J Gastroenterol       Date:  2002-01       Impact factor: 10.864

5.  Evoked potentials in assessment and follow-up of patients with Wilson's disease.

Authors:  G Grimm; W Oder; L Prayer; P Ferenci; C Madl
Journal:  Lancet       Date:  1990-10-20       Impact factor: 79.321

6.  Responses to cued signals in Parkinson's disease. Distinguishing between disorders of cognition and of activation.

Authors:  E Wascher; R Verleger; P Vieregge; P Jaskowski; S Koch; D Kömpf
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

7.  Acute liver failure.

Authors:  J Bernuau; F Durand; P Werner; A Sauvanet; S Erlinger; J Belghiti
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

8.  Auditory brainstem potentials in chronic alcoholics.

Authors:  H Begleiter; B Porjesz; C L Chou
Journal:  Science       Date:  1981-03-06       Impact factor: 47.728

9.  Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.

Authors:  M Romero-Gómez; F Boza; M S García-Valdecasas; E García; J Aguilar-Reina
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

10.  T2 hyperintensity along the cortico-spinal tract in cirrhosis relates to functional abnormalities.

Authors:  Juan Córdoba; Nuria Raguer; Montserrat Flavià; Víctor Vargas; Carlos Jacas; Juli Alonso; Alex Rovira
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

View more
  6 in total

1.  P300 cognitive evoked potentials before and after liver transplantation.

Authors:  Roy R Reeves; Frederick A Struve; Carla J Rash; Randy S Burke
Journal:  Metab Brain Dis       Date:  2007-04-25       Impact factor: 3.584

2.  Guanosine Exerts Neuroprotective Effect in an Experimental Model of Acute Ammonia Intoxication.

Authors:  G F Cittolin-Santos; A M de Assis; P A Guazzelli; L G Paniz; J S da Silva; M E Calcagnotto; G Hansel; K C Zenki; E Kalinine; M M Duarte; D O Souza
Journal:  Mol Neurobiol       Date:  2016-04-06       Impact factor: 5.590

3.  Neuroprotective effects of guanosine administration on behavioral, brain activity, neurochemical and redox parameters in a rat model of chronic hepatic encephalopathy.

Authors:  L G Paniz; M E Calcagnotto; P Pandolfo; D G Machado; G F Santos; G Hansel; R F Almeida; R S Bruch; L M Brum; F V Torres; A M de Assis; E P Rico; D O Souza
Journal:  Metab Brain Dis       Date:  2014-05-01       Impact factor: 3.584

4.  Driving Performance Among Patients with Cirrhosis Who Drove to Their Outpatient Hepatology Clinic Appointments.

Authors:  Paul J Thuluvath; Anantha Nuthalapati; Jennifer Price; Anurag Maheshwari
Journal:  J Clin Exp Hepatol       Date:  2015-10-03

5.  Alpha coma evolving into spindle coma in a case of acute fulminant hepatic failure: What does it signify?

Authors:  Abhijit Das; Ajith Cherian; G K Dash; Ashalatha Radhakrishnan
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

6.  Management of hepatic encephalopathy by traditional chinese medicine.

Authors:  Chun Yao; Nong Tang; Guoxiang Xie; Xiaojiao Zheng; Ping Liu; Lei Fu; Wu Xie; Fan Yao; Houkai Li; Wei Jia
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-05       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.